TD Cowen Reiterates Buy Rating on Aspen Aerogels (ASPN)

TD Cowen analyst Jeffrey Osborne reiterated a Buy rating and $41.00 price target on Aspen Aerogels (NYSE: ASPN).

The analyst commented, "The DOE announced conditional approval loan (up to $670.6mn) for Aspen's paused Georgia plant. The loan highlights demand for additional capacity to supply OEMs with Aspen's EV thermal barrier product (demand for plant expected 2H27). Focus now shifts to closing the loan to help secure funding. 3Q preliminary revenue and EBITDA beat appears driven by GM EV ramp."

For an analyst ratings summary and ratings history on Aspen Aerogels click here. For more ratings news on Aspen Aerogels click here.

Shares of Aspen Aerogels closed at $22.44 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Berkshire adds significantly to Alphabet position, starts small position in DR Horton
• Aurora Spine settles patent dispute, secures $600K insider loan